FibroGen Inc (FGEN)
0.3954
+0.01
(+2.12%)
USD |
NASDAQ |
Nov 22, 16:00
0.40
0.00 (0.00%)
After-Hours: 20:00
FibroGen Shares Outstanding: 100.77M for Oct. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
October 31, 2024 | 100.77M |
September 30, 2024 | 100.77M |
July 31, 2024 | 100.40M |
June 30, 2024 | 100.40M |
April 30, 2024 | 99.48M |
April 08, 2024 | 99.47M |
March 31, 2024 | 99.47M |
January 31, 2024 | 98.77M |
December 31, 2023 | 98.77M |
October 31, 2023 | 98.34M |
September 30, 2023 | 98.34M |
July 31, 2023 | 98.21M |
June 30, 2023 | 98.20M |
April 30, 2023 | 97.58M |
April 10, 2023 | 96.70M |
March 31, 2023 | 96.62M |
January 31, 2023 | 94.18M |
December 31, 2022 | 94.17M |
October 31, 2022 | 93.96M |
September 30, 2022 | 93.94M |
July 31, 2022 | 93.74M |
June 30, 2022 | 93.73M |
April 30, 2022 | 93.30M |
April 18, 2022 | 93.29M |
March 31, 2022 | 93.29M |
Date | Value |
---|---|
January 31, 2022 | 93.00M |
December 31, 2021 | 92.88M |
October 31, 2021 | 92.71M |
September 30, 2021 | 92.71M |
July 31, 2021 | 92.62M |
June 30, 2021 | 92.61M |
April 30, 2021 | 92.13M |
March 31, 2021 | 92.08M |
March 29, 2021 | 92.07M |
January 31, 2021 | 91.56M |
December 31, 2020 | 91.44M |
October 31, 2020 | 91.01M |
September 30, 2020 | 90.88M |
July 31, 2020 | 90.36M |
June 30, 2020 | 90.23M |
April 30, 2020 | 89.10M |
April 09, 2020 | 89.07M |
March 31, 2020 | 88.90M |
January 31, 2020 | 88.00M |
December 31, 2019 | 87.66M |
October 31, 2019 | 87.25M |
September 30, 2019 | 87.21M |
July 31, 2019 | 86.92M |
June 30, 2019 | 86.85M |
April 30, 2019 | 86.22M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
87.66M
Minimum
Dec 31 2019
100.77M
Maximum
Sep 30 2024
94.38M
Average
93.30M
Median
Apr 30 2022
Shares Outstanding Benchmarks
Biomarin Pharmaceutical Inc | 190.58M |
Arbutus Biopharma Corp | 189.49M |
GlycoMimetics Inc | 64.48M |
Cidara Therapeutics Inc | 7.047M |
Cue Biopharma Inc | 63.35M |